Delivery Order SPE2DR25D1053-SPE2DR26FT352
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,025.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 6, 2025, for $5,578.34 to supply 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiovascular treatment. This is a firm fixed price, non-competitive delivery order executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 3, 2025, by the Defense Logistics Agency for the supply of MULTAQ 400 mg tablets (60-count packages) with a ceiling value of $2,847.93. This competitive, firm fixed-price delivery order, which is due for completion by November 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,841.13 on May 30, 2025, for the supply of Multaq 400 mg tablets (60-count units) to support federal medical procurement needs. This firm fixed-price, competitively awarded contract (no set-aside designation) is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. The delivery order is funded through the Defense Medical Supply Chain, a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $39,351.89. This competitive, non-set-aside award utilizes firm fixed-price pricing and is expected to be completed by September 19, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 6, 2025, for supply of MULTAQ 400 MG Tablet 60-count units, with a ceiling value of $19,158.18. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively procured without a set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Multaq 400 mg tablets (60-count) with a ceiling value of $38,737.23. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order (Contract No. 4569889035) by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Multaq 400 mg tablets (60-count packages) at a ceiling value of $2,162.78. The contract carries a firm fixed price structure with an ultimate completion date of November 3, 2025, and represents a competitive award with no set-aside designation. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $28,708.59. This firm fixed-price contract, issued through the Defense Logistics Agency's Medical Supply Chain, represents a competitive award with no set-aside designation. The ultimate completion date is set for August 8, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a $1,718.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order was competitively awarded with no set-aside designation, reflecting...